DexCom (DXCM) Tops Q2 EPS by 5c, Names CFO
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
DexCom (DXCM) PT Lowered to $90 at BMO Capital Following 2Q on 'Near-Term Medicare Reimbursement Disruption'
August 2, 2017 9:49 AM EDTBMO Capital lowered its price target on DexCom (NASDAQ: DXCM) to $90.00 (from $105.00) while maintaining a Outperform rating, following the company's second quarter earnings announcement.
Analyst Joanne Wuensch notes the company delivered second quarter earnings per share and revenue results above consensus projections, while... More
DexCom (DXCM) PT Lowered to $92 at Oppenheimer Following 2Q
August 2, 2017 9:36 AM EDTOppenheimer lowered its price target on DexCom (NASDAQ: DXCM) to $92.00 (from $98.00) while maintaining a Outperform rating. 2Q17 revenue of $170.6M was ahead of the consensus estimate of $166.6M. The beat was both in the US and international. US sales were ~$140.8M, above... More
